BioCardia, Inc. (BCDA)

BioCardia Statistics

Total Valuation

BioCardia has a market cap or net worth of $10.27 million. The enterprise value is $6.38 million.

Market Cap	10.27M
Enterprise Value	6.38M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

BioCardia has 4.58 million shares outstanding. The number of shares has increased by 47.00% in one year.

Current Share Class	4.58M
Shares Outstanding	4.58M
Shares Change (YoY)	+47.00%
Shares Change (QoQ)	+50.63%
Owned by Insiders (%)	18.33%
Owned by Institutions (%)	2.26%
Float	3.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	62.23
Forward PS	503.37
PB Ratio	3.68
P/TBV Ratio	3.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	89.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.38.

Current Ratio	1.78
Quick Ratio	1.74
Debt / Equity	0.38
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -737.89% and return on invested capital (ROIC) is -213.96%.

Return on Equity (ROE)	-737.89%
Return on Assets (ROA)	-96.91%
Return on Capital (ROIC)	-213.96%
Revenue Per Employee	$3,550
Profits Per Employee	-$386,100
Employee Count	20
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.00% in the last 52 weeks. The beta is 1.26, so BioCardia's price volatility has been higher than the market average.

Beta (5Y)	1.26
52-Week Price Change	-77.00%
50-Day Moving Average	2.22
200-Day Moving Average	3.43
Relative Strength Index (RSI)	50.91
Average Volume (20 Days)	45,879

Short Selling Information

The latest short interest is 83,357, so 1.82% of the outstanding shares have been sold short.

Short Interest	83,357
Short Previous Month	103,598
Short % of Shares Out	1.82%
Short % of Float	2.24%
Short Ratio (days to cover)	1.41

Income Statement

In the last 12 months, BioCardia had revenue of $71,000 and -$7.72 million in losses. Loss per share was -$3.92.

Revenue	71,000
Gross Profit	-4.06M
Operating Income	-7.76M
Pretax Income	-10.34M
Net Income	-7.72M
EBITDA	-7.69M
EBIT	-7.76M
Loss Per Share	-$3.92

Balance Sheet

The company has $4.93 million in cash and $1.05 million in debt, giving a net cash position of $3.89 million or $0.85 per share.

Cash & Cash Equivalents	4.93M
Total Debt	1.05M
Net Cash	3.89M
Net Cash Per Share	$0.85
Equity (Book Value)	2.75M
Book Value Per Share	0.61
Working Capital	2.22M

Cash Flow

In the last 12 months, operating cash flow was -$7.30 million and capital expenditures -$5,000, giving a free cash flow of -$7.31 million.

Operating Cash Flow	-7.30M
Capital Expenditures	-5,000
Free Cash Flow	-7.31M
FCF Per Share	-$1.59

Margins

Gross Margin	n/a
Operating Margin	-10,935.21%
Pretax Margin	-10,876.06%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioCardia does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-47.00%
Shareholder Yield	-47.00%
Earnings Yield	-75.20%
FCF Yield	-71.18%

Analyst Forecast

The average price target for BioCardia is $25.00, which is 1,016.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.00
Price Target Difference	1,016.07%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	78.19%
EPS Growth Forecast (5Y)	-33.69%

Stock Splits

The last stock split was on May 30, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	May 30, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

BioCardia has an Altman Z-Score of -37.2 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-37.2
Piotroski F-Score	2